LII Short Interest at a Year High Ahead of Tuesday's Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Lennox International is the most shorted name among its closest building-products peers heading into Tuesday's October 28 earnings release, with short interest at 7.6% of free float, the highest level in at least a year.
Peer context makes the positioning more striking. MAS and AOS both gained around 4% last week, broadly in line with the 4.2% median across the peer group. LII itself rose 5.1% over the same period, outpacing that median, yet shorts have not retreated. The 30-day change in short interest is up 39%, a sustained build rather than a temporary spike. Over the past two weeks specifically, the share count borrowed climbed from roughly 2.2 million to 2.7 million as the stock recovered from its July collapse.
The borrow market is not signalling stress. Availability is running at 408%, meaning there are roughly four shares available to lend for every one already borrowed, well clear of any squeeze conditions. Cost to borrow is 0.54%, essentially free. The ORTEX short score of 55.4 has been range-bound all month, reflecting elevated positioning rather than an accelerating build. Options traders, however, are more defensive: the put/call ratio hit 1.43 on Thursday, more than two standard deviations above its 20-day average, the most skewed reading in recent months even if well below the 52-week peak of 2.34.
The analyst community has turned measurably cooler. Goldman Sachs downgraded from Buy to Neutral on October 14 and cut its target from $547 to $390. Morgan Stanley, already at Underweight, trimmed its target again to $350. Several others, including Mizuho and RBC Capital, maintained ratings but cut targets by 10% to 15%. The consensus mean target stands at $449, implying significant upside from the current $376, but the direction of recent moves is uniformly downward. That target spread reflects the core disagreement: some analysts still price in a recovery in residential HVAC demand as destocking ends and housing activity picks up, while the sceptics point to the 23% volume decline posted in July and a guidance trajectory that has been revised lower at each reporting cycle.
One structural overlay sits outside the earnings story but cannot be separated from it. ORTEX puts an 88% probability on LII being removed from the MSCI USA, MSCI World, MSCI Kokusai, and MSCI North America indices at the November 2026 Quarterly Review, with a combined selling flow of up to $710M forecast across the largest deletions. The stock needs to close above $461 to avoid that outcome, roughly 23% above current levels. The rank date has already passed. An announcement is expected November 11, with the trade date November 30. A strong earnings print that closes even part of that gap would change the mechanical picture; a miss would cement it.
The October 28 report is therefore a test of whether the residential recovery narrative can survive contact with actual Q3 numbers, and whether that result is enough to shift the index arithmetic before the November announcement window closes.
Stocks in this article
See the live data behind this article on ORTEX.
Open LII on ORTEX →How this article was generated
- Generated
- 25 Oct 2026, 04:06
- Data as of
- 25 Oct 2026, 03:55
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex RebalancePrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.